SureTrader
Interactive Brokers Advertisement
Home > Boards > US Listed > Biotechs > Intellipharmaceutics International Inc. (IPCI)

Yep, meanwhile Movie Pass still stirs up the

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Tekterra Member Profile
 
Followed By 17
Posts 1,827
Boards Moderated 1
Alias Born 03/29/16
160x600 placeholder
Statement of Ownership (sc 13g) "Edgar (US Regulatory)" - 10/20/2017 5:20:34 PM
Small Company Offering and Sale of Securities Without Registration (d) "Edgar (US Regulatory)" - 10/18/2017 3:20:22 PM
Report of Foreign Issuer (6-k) "Edgar (US Regulatory)" - 10/16/2017 6:03:43 AM
Intellipharmaceutics Announces Closing of US$4 Million Financing "GlobeNewswire Inc." - 10/13/2017 5:45:00 PM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) "Edgar (US Regulatory)" - 10/13/2017 6:04:15 AM
Report of Foreign Issuer (6-k) "Edgar (US Regulatory)" - 10/12/2017 4:07:48 PM
Report of Foreign Issuer (6-k) "Edgar (US Regulatory)" - 10/11/2017 8:07:45 AM
Intellipharmaceutics Announces US$4 Million Registered Direct Offering "GlobeNewswire Inc." - 10/11/2017 8:00:00 AM
Report of Foreign Issuer (6-k) "Edgar (US Regulatory)" - 10/10/2017 5:25:56 PM
Intellipharmaceutics Announces Third Quarter 2017 Results "GlobeNewswire Inc." - 10/10/2017 5:20:59 PM
Report of Foreign Issuer (6-k) "Edgar (US Regulatory)" - 9/25/2017 7:12:00 AM
Intellipharmaceutics Receives Complete Response Letter from the FDA for Rexista™ NDA "GlobeNewswire Inc." - 9/25/2017 7:00:00 AM
Report of Foreign Issuer (6-k) "Edgar (US Regulatory)" - 9/20/2017 5:18:47 PM
Intellipharmaceutics Announces Receipt of Nasdaq Notice "GlobeNewswire Inc." - 9/20/2017 5:10:00 PM
Report of Foreign Issuer (6-k) "Edgar (US Regulatory)" - 9/5/2017 2:43:50 PM
Intellipharmaceutics Provides Operational Update "GlobeNewswire Inc." - 9/5/2017 2:35:00 PM
Report of Foreign Issuer (6-k) "Edgar (US Regulatory)" - 9/1/2017 8:10:22 AM
Intellipharmaceutics Appoints New Chief Financial Officer "GlobeNewswire Inc." - 9/1/2017 8:00:00 AM
Monteverde & Associates PC Invites IntelliPharmaCeutics International Inc. Shareholders with Losses in Excess of $1... "PR Newswire (US)" - 8/15/2017 4:52:00 PM
Report of Foreign Issuer (6-k) "Edgar (US Regulatory)" - 8/8/2017 3:06:36 PM
Intellipharmaceutics Announces Resignation of Chief Financial Officer "GlobeNewswire Inc." - 8/8/2017 3:00:00 PM
Report of Foreign Issuer (6-k) "Edgar (US Regulatory)" - 7/31/2017 8:10:21 AM
Intellipharmaceutics Intends to Vigorously Defend Recently Filed Purported Class Action Lawsuit "GlobeNewswire Inc." - 7/31/2017 8:00:00 AM
Report of Foreign Issuer (6-k) "Edgar (US Regulatory)" - 7/27/2017 6:07:34 AM
Intellipharmaceutics Provides Update on FDA Advisory Committees Meeting for Rexista™ (oxycodone hydrochloride extended rele... "GlobeNewswire Inc." - 7/26/2017 8:15:00 PM
Tekterra   Thursday, 11/09/17 11:31:06 AM
Re: doogdilinger post# 31174
Post # of 31358 
Yep, meanwhile Movie Pass still stirs up the film industry that remains to be seen whether or not it will be the Netflex of movie going experience.

It's risky but success means another Netflex in the making. Netflext from 2010 was about 10$, 6 years later touched 200$. That's the kind of retirement stock.

HMNY owner of MP is just like Netflex in the beginning about 10$ a share. It started in the 2-3$ range back in August. However, this one is a bit different. MP did not merge with HMNY, instead HMNY toke a controlling stake and will now be owning up to 64% of MP. MP is planning on going public on its own with the help of HMNY. In any case, HMNY value is going to be 64% of what MP is worth.


Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist